Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
March 23, 2026
Inactivated Japanese encephalitis virus vaccination imprints fusion loop-biased antibody responses that are attenuated by repeated live-attenuated dengue vaccination
Patrick I Mpingabo, Esther I Adekomi, Lisa A Ware, et al.
Frontiers in Immunology
|
December 13, 2021
Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection
Adam D Wegman, Hengsheng Fang, Alan L Rothman, et al.
NPJ Vaccines
|
November 1, 2022
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults
Heather Friberg, Morgan Gargulak, Amanda Kong, et al.
Plos Neglected Tropical Diseases
|
December 18, 2018
Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection
Heather Friberg, Coreen M Beaumier, Sangshin Park, et al.
The Journal of Infectious Diseases
|
March 13, 2024
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity
Luis A Sanchez-Vargas, Anuja Mathew, Henrik Salje, et al.
Scientific Reports
|
February 23, 2012
Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans
Heather Friberg, Hema Bashyam, Tomoko Toyosaki-Maeda, et al.
Msphere
|
January 24, 2020
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1
Heather Friberg, Luis J Martinez, Leyi Lin, et al.
Scientific Reports
|
June 5, 2020
Analysis of cell-associated DENV RNA by oligo(dT) primed 5' capture scRNAseq
Mark A Sanborn, Tao Li, Kaitlin Victor, et al.
Human Vaccines & Immunotherapeutics
|
March 5, 2019
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions
Philippe Moris, Kristen M Bauer, Jeffrey R Currier, et al.
Nature Microbiology
|
April 1, 2024
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study
Adam T Waickman, Krista Newell, Joseph Q Lu, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Medrxiv : the Preprint Server for Health Sciences
|
March 23, 2026
Inactivated Japanese encephalitis virus vaccination imprints fusion loop-biased antibody responses that are attenuated by repeated live-attenuated dengue vaccination
Patrick I Mpingabo, Esther I Adekomi, Lisa A Ware, et al.
Frontiers in Immunology
|
December 13, 2021
Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection
Adam D Wegman, Hengsheng Fang, Alan L Rothman, et al.
NPJ Vaccines
|
November 1, 2022
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults
Heather Friberg, Morgan Gargulak, Amanda Kong, et al.
Plos Neglected Tropical Diseases
|
December 18, 2018
Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection
Heather Friberg, Coreen M Beaumier, Sangshin Park, et al.
The Journal of Infectious Diseases
|
March 13, 2024
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity
Luis A Sanchez-Vargas, Anuja Mathew, Henrik Salje, et al.
Scientific Reports
|
February 23, 2012
Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans
Heather Friberg, Hema Bashyam, Tomoko Toyosaki-Maeda, et al.
Msphere
|
January 24, 2020
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1
Heather Friberg, Luis J Martinez, Leyi Lin, et al.
Scientific Reports
|
June 5, 2020
Analysis of cell-associated DENV RNA by oligo(dT) primed 5' capture scRNAseq
Mark A Sanborn, Tao Li, Kaitlin Victor, et al.
Human Vaccines & Immunotherapeutics
|
March 5, 2019
Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions
Philippe Moris, Kristen M Bauer, Jeffrey R Currier, et al.
Nature Microbiology
|
April 1, 2024
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study
Adam T Waickman, Krista Newell, Joseph Q Lu, et al.
Page
of 5